Platform products for self-injection
Product Gallery
Information
Ypsomed’s platform portfolio offers advanced self-injection devices, including reusable and prefilled pens, autoinjectors, wearable injectors, and digital health solutions. Each platform is engineered in Switzerland for fast, efficient customisation, significantly reducing time to market and minimising development risks by using pre-developed, proven technologies.
The adaptable manufacturing processes support both small-scale clinical trials and high-volume commercial production, ensuring scalability as needed. This flexibility enables an efficient transition from development to market, providing reliable, safe drug delivery solutions at every stage.
Country
Switzerland
Product Type
Self-injection devices
Application Areas
For biologics and small molecules. For a broad range of therapies, such as hormone therapies (hGH, FSH), autoimmune diseases, diabetes, obesity, rare diseases, oncology
Key Features
Designed and developed in Switzerland. Fast and easy customisation. Patented products minimise project risks. Proven safety through human factor studies. Advanced large-scale automation. Compliant with international regulatory standards.
